Metraipolis › archive › dc_19c6340bbf8d

PCSK9 in Cancer: Biological Mechanisms and Implications for Therapeutic Resistance — Europe PMC PMID:41594607

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41594607
DOI
10.3390/biom16010067
License (as archived)
solo-consultazione
Archived
2026-11-07T07:37:26.751Z
SHA-256 of the archived text
7054096b813456545d3b2e3bc2c9151a58793664a29e2e3052db9a82bebd8d64
Stable URL of this page
https://metraipolis.com/documento/dc_19c6340bbf8d

How to cite

PCSK9 in Cancer: Biological Mechanisms and Implications for Therapeutic Resistance — Europe PMC PMID:41594607 — Europe PMC (en), https://europepmc.org/article/MED/41594607 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19c6340bbf8d (Metraipolis archive dc_19c6340bbf8d, sha256 7054096b813456545d3b2e3bc2c9151a58793664a29e2e3052db9a82bebd8d64)
BibTeX
@misc{dc19c6340bbf8d,
  title = {PCSK9 in Cancer: Biological Mechanisms and Implications for Therapeutic Resistance — Europe PMC PMID:41594607},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41594607},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19c6340bbf8d; sha256 7054096b813456545d3b2e3bc2c9151a58793664a29e2e3052db9a82bebd8d64},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41594607. Agents can read the archived copy with the MCP tool read_document.